- Home
- BBDO vs DXCM Comparison
BBDO vs DXCM Comparison
Compare BBDO & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBDO | DXCM |
|---|---|---|
| Founded | 1943 | 1999 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | BBDO | DXCM |
|---|---|---|
| Price | $3.02 | $66.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 21 |
| Target Price | $2.55 | ★ $87.90 |
| AVG Volume (30 Days) | 52.4K | ★ 5.3M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | ★ 5.04% | N/A |
| EPS Growth | ★ 47.11 | 7.75 |
| EPS | 0.38 | ★ 1.80 |
| Revenue | ★ $16,507,289,161.00 | $4,515,900,000.00 |
| Revenue This Year | $78.26 | $17.41 |
| Revenue Next Year | $7.53 | $12.78 |
| P/E Ratio | ★ $8.41 | $38.37 |
| Revenue Growth | ★ 16.68 | 14.21 |
| 52 Week Low | $1.71 | $54.11 |
| 52 Week High | $3.31 | $93.25 |
Technical Indicators
Market Signals| Indicator | BBDO | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 60.62 |
| Support Level | $2.82 | $64.00 |
| Resistance Level | $3.02 | $69.77 |
| Average True Range (ATR) | 0.09 | 1.96 |
| MACD | -0.03 | 0.78 |
| Stochastic Oscillator | 45.00 | 72.06 |
Price Performance
Historical ComparisonAbout BBDO Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.